CITIGROUP INC - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 38 filers reported holding HUMACYTE INC in Q3 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$3,853
-93.3%
1,315
-93.4%
0.00%
Q2 2023$57,171
+1474.5%
19,990
+1601.3%
0.00%
Q1 2023$3,631
-49.0%
1,175
-65.2%
0.00%
Q4 2022$7,115
-28.8%
3,372
+7.5%
0.00%
Q3 2022$10,000
-23.1%
3,138
-25.1%
0.00%
Q2 2022$13,000
-84.5%
4,187
-64.7%
0.00%
Q1 2022$84,000
+189.7%
11,859
+191.7%
0.00%
Q4 2021$29,000
-38.3%
4,066
+0.1%
0.00%
Q3 2021$47,0004,0620.00%
Other shareholders
HUMACYTE INC shareholders Q3 2021
NameSharesValueWeighting ↓
York Capital Management Global Advisors, LLC 2,291,397$16,613,0003.70%
Monashee Investment Management LLC 399,910$2,899,0000.72%
Endowment Wealth Management, Inc. 96,618$700,0000.71%
Gladstone Institutional Advisory LLC 246,717$1,7890.14%
Diameter Capital Partners LP 300,338$2,177,0000.13%
CenterBook Partners LP 23,706$172,0000.10%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 900,100$6,526,000,0000.06%
Exos Asset Management LLC 16,139$117,0000.06%
Maven Securities LTD 200,000$1,450,0000.04%
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV 11,000$80,0000.04%
View complete list of HUMACYTE INC shareholders